Lexaria Bioscience Corp. (LEXX) Financials
LEXX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2024-02-29 | 6.4 million | 204203 |
| 2023-11-30 | 3.6 million | 254040 |
| 2023-08-31 | 3.1 million | 403908 |
| 2023-05-31 | 5.2 million | 1.2 million |
LEXX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2024-02-29 | -676604 | ? |
| 2023-11-30 | -1.2 million | 53953 |
| 2023-08-31 | -1.7 million | 9634 |
| 2023-05-31 | -1.8 million | 81446 |
LEXX Net Income
No data available :(
LEXX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2024-02-29 | - | - | 148885 |
| 2023-11-30 | 2.0 million | - | 155071 |
| 2023-08-31 | 1.5 million | - | 163967 |
| 2023-05-31 | 3.4 million | - | 174904 |
LEXX Shares Outstanding
LEXX Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2024-02-29 | 56990 | 245779 | 567226 | - |
| 2023-11-30 | 40026 | 574491 | 711107 | - |
| 2023-08-31 | 68437 | 500406 | 566673 | - |
| 2023-05-31 | 33647 | 1.6 million | 823321 | - |
LEXX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2024-02-29 | 145000 | - |
| 2023-11-30 | 151278 | 4822 |
| 2023-08-31 | -3433 | 3433 |
| 2023-05-31 | 93150 | 12747 |
LEXX
Price: $3.13
52 week price:
Earnings Per Share: -0.84 USD
P/E Ratio: -2.04
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 7400
Market Capitalization: 30.2 million